Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on December 6th, 2023%
A developer of treatments for cancer and autoimmune disorders from stem cells says FDA cleared its request to start a clinical trial of its therapy for systemic lupus erythematosus. . . . → Read More: Trial Okayed for Gene-Edited Stem Cell Lupus Treatment
By Alan, on November 24th, 2023%
Researchers from university labs in the U.K. are developing models of brain cell interactions using a company’s synthetic human cells derived from stem cells. . . . → Read More: Academic, Industry Labs to Build Brain Cell Models
By Alan, on November 22nd, 2023%
A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding. . . . → Read More: Lab-Grown Tissue Company Gains $38M in Seed Funds
By Alan, on November 17th, 2023%
Health authorities in Sweden authorized the start of a clinical trial testing insulin-producing cells from donors engineered to prevent immune reactions in people with type 1 diabetes. . . . → Read More: Trial Okayed to Transplant Donated Islet Cells for Type 1 Diabetes
By Alan, on September 29th, 2023%
A company with a process to generate new thymus tissue for immune system functions is receiving a $37 million award from the government’s health breakthrough agency. . . . → Read More: Biotech Thymus Tissue Process Gains ARPA-H Funding
By Alan, on September 8th, 2023%
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies. . . . → Read More: Neurons from Stem Cells Produced for Overdose Therapy Tests
By Alan, on August 16th, 2023%
A clinical trial has begun testing an experimental treatment for burns using off-the-shelf therapeutic particles derived from human bone marrow stem cells. . . . → Read More: Trial Underway Testing Stem Cell Particles for Burns
By Alan, on July 27th, 2023%
A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive. . . . → Read More: Streamlined Gene Therapy Delivery Process Demonstrated
By Alan, on July 25th, 2023%
A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage
By Alan, on July 18th, 2023%
A clinical trial, testing stem cells for neurons fortified with tumor-killing viruses, administered its first doses to a patient with glioma, an aggressive type of brain cancer. . . . → Read More: Trial Underway Testing Engineered Cancer-Killing Viruses
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|